Document Detail


Pregnancy in Marfan syndrome after aortic root replacement: a case report and review of the literature.
MedLine Citation:
PMID:  18377545     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Marfan syndrome is an inheritable connective tissue disorder with multisystem involvement and variable expression of signs and symptoms, caused by mutations within the fibrillin gene on chromosome 15q21. The reported incidence of severe cardiovascular events during pregnancy in Marfan patients' series is 3-7%, and the overall risk of fatal complication is approximately 1%. Although acute aortic dissection is a rare complication, an association between pregnancy and aortic dissection has been reported even in the absence of preconception aortic root dilatation. DESIGN: Case report and literature review. RESULTS: A 29-year-old pregnant woman with Marfan syndrome after replacement of ascending aorta with aortic valve conservation. She had a normal pregnancy and was delivered at term by cesarean section. CONCLUSION: Successful pregnancy and delivery can be achieved in Marfan's patients after aortic root replacement.
Authors:
Vania Volach; Amir Elami; Dan Gilon; Arthur Pollak; Yehuda Ginosar; Yossef Ezra
Related Documents :
12069735 - Antioxidant enzyme activities are decreased in preterm infants and in neonates born via...
14654315 - Caesarean section and risk of unexplained stillbirth in subsequent pregnancy.
18456075 - Elective cesarean section: its impact on neonatal respiratory outcome.
9874865 - Anesthetic management of a parturient with eisenmenger's syndrome and preeclampsia duri...
12481955 - Pregnancy outcome following women's participation in a randomised controlled trial of a...
8710775 - Immediate changes in umbilical blood flow after transcervical chorionic villus sampling...
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Congenital heart disease     Volume:  1     ISSN:  1747-0803     ISO Abbreviation:  -     Publication Date:  2006 Jul 
Date Detail:
Created Date:  2008-04-01     Completed Date:  2008-04-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101256510     Medline TA:  Congenit Heart Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  184-8     Citation Subset:  IM    
Affiliation:
Obstetrics and Gynecology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Adult
Aneurysm, Dissecting / prevention & control*
Antihypertensive Agents / therapeutic use
Aortic Diseases / etiology,  surgery*
Blood Vessel Prosthesis*
Delivery, Obstetric
Dilatation, Pathologic
Female
Humans
Hydralazine / therapeutic use
Marfan Syndrome / complications,  surgery*
Pregnancy
Pregnancy Complications, Cardiovascular / prevention & control*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Antihypertensive Agents; 86-54-4/Hydralazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rare but fatal complication of umbilical venous catheterization.
Next Document:  Lessons learned from the pediatric heart transplant study.